SEC Comment Letter for Dare Bioscience, Inc. (DARE) (CIK 0001401914) (DARE) — May 8, 2020
Dare Bioscience, Inc. (DARE) (CIK 0001401914)
Date: May 8, 2020 · CIK: 0001401914 · Accession: 0000000000-20-004042
AI Filing Summary & Sentiment
File numbers found in text: 333-237954
Letter
United States securities and exchange commission logo May 7, 2020 Lisa Walters-Hoffert Chief Financial Officer Dare Bioscience, Inc. 3655 Nobel Drive, Suite 260 San Diego, California 92122 Re:Dare Bioscience, Inc. Registration Statement on Form S-1 Filed May 1, 2020 File No. 333-237954 Dear Ms. Walters-Hoffert: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202) 441-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Edwin Astudillo, Esq.
Show Raw Text
United States securities and exchange commission logo
May 7, 2020
Lisa Walters-Hoffert
Chief Financial Officer
Dare Bioscience, Inc.
3655 Nobel Drive, Suite 260
San Diego, California 92122
Re:Dare Bioscience, Inc.
Registration Statement on Form S-1
Filed May 1, 2020
File No. 333-237954
Dear Ms. Walters-Hoffert:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at (202) 441-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Edwin Astudillo, Esq.